Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy

Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy

Source: 
Forbes
snippet: 

So far, 38 biotechnology companies have gone public in 2018, raising nearly $4 billion, according to figures released by Bloomberg last week. That’s the highest amount the biotech sector has raised on the public markets since 2000, when the science was in its infancy. And if there’s one therapeutic area that investors are focusing most closely on, it’s clearly cancer.